Adrenergics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- June 15, 2015
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $10,000,000
Company Info
- Company Description
- Adrenergics is developing novel therapeutics to treat dilated cardiomyopathy (DCM) in patients that do not respond to existing therapies. The company focuses on a key disease driver to develop medicines that are expected to modulate disease progression leading to improved outcomes in this difficult-to-treat patient population.
- Market
- Healthcare
- Location
- La Jolla, CA, USA
- Coinvestors
- avalon Ventures, GlaxoSmithKline